Biophytis (BPTSY) Competitors $3.60 0.00 (0.00%) As of 01/21/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends BPTSY vs. GRAY, PPBT, ALLR, SONN, SNPX, BNOX, ONCO, PRTG, PHIO, and CPHIShould you be buying Biophytis stock or one of its competitors? The main competitors of Biophytis include Graybug Vision (GRAY), Purple Biotech (PPBT), Allarity Therapeutics (ALLR), Sonnet BioTherapeutics (SONN), Synaptogenix (SNPX), Bionomics (BNOX), Onconetix (ONCO), Portage Biotech (PRTG), Phio Pharmaceuticals (PHIO), and China Pharma (CPHI). These companies are all part of the "pharmaceutical preparations" industry. Biophytis vs. Graybug Vision Purple Biotech Allarity Therapeutics Sonnet BioTherapeutics Synaptogenix Bionomics Onconetix Portage Biotech Phio Pharmaceuticals China Pharma Biophytis (NASDAQ:BPTSY) and Graybug Vision (NASDAQ:GRAY) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, community ranking, earnings and media sentiment. Is BPTSY or GRAY more profitable? Biophytis' return on equity of 0.00% beat Graybug Vision's return on equity.Company Net Margins Return on Equity Return on Assets BiophytisN/A N/A N/A Graybug Vision N/A -77.61%-71.34% Does the MarketBeat Community prefer BPTSY or GRAY? Graybug Vision received 16 more outperform votes than Biophytis when rated by MarketBeat users. CompanyUnderperformOutperformBiophytisN/AN/AGraybug VisionOutperform Votes1650.00% Underperform Votes1650.00% Which has more volatility & risk, BPTSY or GRAY? Biophytis has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500. Comparatively, Graybug Vision has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Which has higher valuation & earnings, BPTSY or GRAY? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiophytisN/AN/A-$18.43MN/AN/AGraybug VisionN/AN/A-$35.60M-$24.23-0.13 Do insiders & institutionals believe in BPTSY or GRAY? 0.1% of Biophytis shares are held by institutional investors. Comparatively, 49.9% of Graybug Vision shares are held by institutional investors. 3.7% of Biophytis shares are held by insiders. Comparatively, 7.9% of Graybug Vision shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer BPTSY or GRAY? In the previous week, Biophytis' average media sentiment score of 0.00 equaled Graybug Vision'saverage media sentiment score. Company Overall Sentiment Biophytis Neutral Graybug Vision Neutral SummaryGraybug Vision beats Biophytis on 4 of the 7 factors compared between the two stocks. Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTSY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BPTSY vs. The Competition Export to ExcelMetricBiophytisPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.26M$6.56B$5.38B$9.13BDividend YieldN/A2.96%5.37%4.00%P/E RatioN/A9.3686.9417.29Price / SalesN/A329.751,267.38137.12Price / CashN/A22.6336.6032.88Price / Book-0.225.084.974.69Net Income-$18.43M$154.90M$117.89M$224.57M7 Day PerformanceN/A1.33%1.72%1.69%1 Month Performance18.03%1.51%3.67%5.34%1 Year PerformanceN/A4.60%26.11%21.47% Biophytis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BPTSYBiophytisN/A$3.60flatN/AN/A$1.26MN/A0.0022News CoverageGRAYGraybug VisionN/A$3.09-2.5%N/A-35.4%$4.85MN/A-1.7927High Trading VolumePPBTPurple Biotech1.3018 of 5 stars$3.54-4.8%$33.00+832.2%N/A$4.71MN/A-0.4020ALLRAllarity Therapeutics0.6124 of 5 stars$1.05+1.9%N/A-99.6%$4.65MN/A0.0010Gap UpSONNSonnet BioTherapeutics2.9918 of 5 stars$1.54flat$20.00+1,198.7%+15.8%$4.64M$20,000.000.0010News CoveragePositive NewsSNPXSynaptogenix2.041 of 5 stars$3.30flat$14.00+324.2%-44.5%$4.49MN/A0.004Negative NewsBNOXBionomics1.6235 of 5 stars$0.25+4.2%$8.00+3,060.8%-75.9%$4.47M$10,000.000.00N/AGap UpHigh Trading VolumeONCOOnconetix0.1548 of 5 stars$0.53+3.4%N/A-92.1%$4.40M$1.87M0.0012Gap UpPRTGPortage Biotech0.0713 of 5 stars$4.10+3.5%N/A-80.6%$4.31MN/A-0.106Negative NewsGap UpPHIOPhio Pharmaceuticals2.4752 of 5 stars$2.77-4.8%$36.00+1,199.6%-59.2%$4.13MN/A-0.2510News CoverageGap DownHigh Trading VolumeCPHIChina PharmaN/A$0.21+1.0%N/A-53.5%$4.04M$7.01M0.00231Gap Down Related Companies and Tools Related Companies Graybug Vision Alternatives Purple Biotech Alternatives Allarity Therapeutics Alternatives Sonnet BioTherapeutics Alternatives Synaptogenix Alternatives Bionomics Alternatives Onconetix Alternatives Portage Biotech Alternatives Phio Pharmaceuticals Alternatives China Pharma Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BPTSY) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biophytis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biophytis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BPTSY Stock Alerts